Literature DB >> 14963180

The effect of initial shunt outflow position on patency of transjugular intrahepatic portosystemic shunts.

Timothy W I Clark1, Rajan Agarwal, Ziv J Haskal, S William Stavropoulos.   

Abstract

PURPOSE: It has been suggested that initial stent position in transjugular intrahepatic portosystemic shunts (TIPS) with relation to hepatic venous outflow is an important determinant of shunt patency. It was hypothesized that TIPS with the stent-implanted segments terminating in the hepatic vein (HV) have shorter primary unassisted shunt patency durations than TIPS with the stent-implanted segments extending to the hepatocaval junction.
MATERIALS AND METHODS: A consecutive group of 107 patients who underwent TIPS creation for variceal bleeding were retrospectively identified, and the angiographic images during initial TIPS creation were reviewed independently by two observers who were blinded to outcome. Primary unassisted patency was estimated in group A (TIPS terminating in the HV; n = 47) and group B (TIPS terminating at the hepatocaval junction; n = 60) with the Kaplan-Meier method, and the two groups were compared with the log-rank test. Patients who had less than 30 days of follow-up were excluded from the analysis.
RESULTS: Among all 107 patients, primary unassisted patency rates at 3, 6, and 12 months were 91% +/- 4%, 74% +/- 6%, and 49% +/- 6%. TIPS were classified into group A or group B with high interobserver agreement (Cohen kappa = 0.98). At 12 months, the primary unassisted patency rate among the patients in group A was 36% +/- 10%, compared with 58% +/- 8% among the patients in group B (P =.017, log-rank test). Patients in group A were twice as likely to lose patency than patients in group B (95% CI of odds ratio, 1.2-4.5). Thirty-day mortality was similar between groups (15% vs 12%; P =.13).
CONCLUSION: Initial stent position within the hepatic venous outflow is predictive of shunt patency, with TIPS extending to the hepatocaval junction having a longer lifespan than shunts terminating in the HV.

Entities:  

Mesh:

Year:  2004        PMID: 14963180     DOI: 10.1097/01.rvi.0000109401.52762.56

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  15 in total

Review 1.  Hepatic applications of endoscopic ultrasound: Current status and future directions.

Authors:  Indu Srinivasan; Shou-Jiang Tang; Andreas S Vilmann; John Menachery; Peter Vilmann
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

2.  Stent-grafts for the treatment of TIPS dysfunction: fluency stent vs Wallgraft stent.

Authors:  Xue-Feng Luo; Ling Nie; Zhu Wang; Jiaywei Tsauo; Ling-Jun Liu; Yang Yu; Biao Zhou; Cheng-Wei Tang; Xiao Li
Journal:  World J Gastroenterol       Date:  2013-08-14       Impact factor: 5.742

3.  Transjugular intrahepatic portosystemic shunt-related complications and practical solutions.

Authors:  Renato Ripamonti; Hector Ferral; Marc Alonzo; Nilesh H Patel
Journal:  Semin Intervent Radiol       Date:  2006-06       Impact factor: 1.513

4.  Combined Y-configured stents for revising occluded transjugular intrahepatic portosystemic shunt.

Authors:  Xiaoze Wang; Yongjun Zhu; Ming Zhu; Xuefeng Luo; Li Yang
Journal:  Diagn Interv Radiol       Date:  2021-03       Impact factor: 2.630

Review 5.  Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: an evidence-based review.

Authors:  Xing-Shun Qi; Ming Bai; Zhi-Ping Yang; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

6.  Effect of technical parameters on transjugular intrahepatic portosystemic shunts utilizing stent grafts.

Authors:  Brice Andring; Sanjeeva P Kalva; Patrick Sutphin; Rajiv Srinivasa; Alvin Anene; Marc Burrell; Yin Xi; Anil K Pillai
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

7.  Predicting death or recurrence of portal hypertension symptoms after TIPS procedures.

Authors:  Shawn H Sun; Thomas Eche; Chloé Dorczynski; Philippe Otal; Paul Revel-Mouroz; Charline Zadro; Ephraim Partouche; Nadim Fares; Charlotte Maulat; Christophe Bureau; Lawrence H Schwartz; Hervé Rousseau; Laurent Dercle; Fatima-Zohra Mokrane
Journal:  Eur Radiol       Date:  2022-01-11       Impact factor: 5.315

8.  Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.

Authors:  Ming Bai; Chuang-Ye He; Xing-Shun Qi; Zhan-Xin Yin; Jian-Hong Wang; Wen-Gang Guo; Jing Niu; Jie-Lai Xia; Zhuo-Li Zhang; Andrew C Larson; Kai-Chun Wu; Dai-Ming Fan; Guo-Hong Han
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

9.  Parallel shunt for the treatment of transjugular intrahepatic portosystemic shunt dysfunction.

Authors:  Xuefeng Luo; Ling Nie; Jiaywei Tsauo; Zhu Wang; Chengwei Tang; Xiao Li
Journal:  Korean J Radiol       Date:  2013-05-02       Impact factor: 3.500

10.  Persistence of gastric or esophageal varices on final angiography increases transjugular intrahepatic portosystemic shunt revision rate after polytetrafluoroethylene-covered stent shunt creation.

Authors:  Benjamin Moulin; Olivier Chevallier; Gilles Abdulmalak; Maxime Luu; Marianne Latournerie; Anne Minello; Sophie Gehin; Jean-Pierre Cercueil; Marco Midulla; Romaric Loffroy
Journal:  Quant Imaging Med Surg       Date:  2018-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.